Stock NANO NANOBIOTIX
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Nanobiotix

Equities

NANO

FR0011341205

Real-time Euronext Paris
Other stock markets
 10:24:15 2024-05-21 am EDT 		5-day change 1st Jan Change
6.44 EUR -1.98% Intraday chart for Nanobiotix -4.81% -3.09%
May. 14 Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment MT
May. 14 Nanobiotix Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating Nbtxr3 for Patients with Stage Three Lung Cancer CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NANOBIOTIX
Other Biotechnology & Medical Research
-1.98%-4.81%-3.09%+34.34%-38.71% 336M
Bullish
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. NANO Stock
  4. Charts Nanobiotix
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW